CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Shareholder vote results
- DEFA14A Proxy Proxy Materials
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Derivatives Options or other derivatives
- 8-K Event Regulation FD disclosure
- PRE 14A Proxy Proxy Statement (Preliminary)
- 144 Insider Sale of Securities
- 4 Planned sale SVP, Chief Commercial Officer sold 10,417 shares at $28.10 ($292,740)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 2,845 shares (to pay taxes)
- 4 Open-market sale VP, Finance (Interim PAO) sold 2,559 shares at $29.65 ($75,874)
- 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 2,587 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CLO, Alkermes, Inc. gave up 3,414 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Corp Dev., Alkermes, Inc. gave up 1,811 shares (to pay taxes)
Page 14 of 97 · 1,927 filings